154 related articles for article (PubMed ID: 16698666)
1. IgA class antibodies to 2-oxo-acid dehydrogenase complex are not predictive markers of histopathological progression in primary biliary cirrhosis.
Omagari K; Kadokawa Y; Nakamura M; Akazawa S; Ohba K; Ohnita K; Mizuta Y; Daikoku M; Yatsuhashi H; Ishibashi H; Kohno S
Autoimmunity; 2006 Mar; 39(2):107-12. PubMed ID: 16698666
[TBL] [Abstract][Full Text] [Related]
2. Correlation between histopathological findings of the liver and IgA class antibodies to 2-oxo-acid dehydrogenase complex in primary biliary cirrhosis.
Masuda J; Omagari K; Ohba K; Hazama H; Kadokawa Y; Kinoshita H; Hayashida K; Hayashida K; Ishibashi H; Nakanuma Y; Kohno S
Dig Dis Sci; 2003 May; 48(5):932-8. PubMed ID: 12772793
[TBL] [Abstract][Full Text] [Related]
3. Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression.
Van Norstrand MD; Malinchoc M; Lindor KD; Therneau TM; Gershwin ME; Leung PS; Dickson ER; Homburger HA
Hepatology; 1997 Jan; 25(1):6-11. PubMed ID: 8985257
[TBL] [Abstract][Full Text] [Related]
4. The clinical significance of IgA antimitochondrial antibodies in sera and saliva in primary biliary cirrhosis.
Tanaka A; Nezu S; Uegaki S; Mikami M; Okuyama S; Kawamura N; Aiso M; Gershwin ME; Takahashi S; Selmi C; Takikawa H
Ann N Y Acad Sci; 2007 Jun; 1107():259-70. PubMed ID: 17804554
[TBL] [Abstract][Full Text] [Related]
5. In situ nucleic acid detection of PDC-E2, BCOADC-E2, OGDC-E2, PDC-E1alpha, BCOADC-E1alpha, OGDC-E1, and the E3 binding protein (protein X) in primary biliary cirrhosis.
Harada K; Sudo Y; Kono N; Ozaki S; Tsuneyama K; Gershwin ME; Nakanuma Y
Hepatology; 1999 Jul; 30(1):36-45. PubMed ID: 10385636
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of positive immunoblotting but negative immunofluorescence for antimitochondrial antibodies in patients with liver diseases other than primary biliary cirrhosis.
Masuda J; Omagar K; Miyakawa H; Hazama H; Ohba K; Kinoshita H; Matsuo I; Isomoto H; Murata I; Kohno S
Autoimmunity; 2002 Mar; 35(2):135-41. PubMed ID: 12071436
[TBL] [Abstract][Full Text] [Related]
7. [The association between autoantibodies to enzyme and diseases--with special reference to antibodies to pyruvate dehydrogenase complex (PDH)].
Moteki S; Amaki S; Nakano E
Rinsho Byori; 1998 Apr; 46(4):317-23. PubMed ID: 9594621
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis.
Papp M; Sipeki N; Vitalis Z; Tornai T; Altorjay I; Tornai I; Udvardy M; Fechner K; Jacobsen S; Teegen B; Sumegi A; Veres G; Lakatos PL; Kappelmayer J; Antal-Szalmas P
J Hepatol; 2013 Sep; 59(3):457-66. PubMed ID: 23639483
[TBL] [Abstract][Full Text] [Related]
9. Mucosal immunity and primary biliary cirrhosis: presence of antimitochondrial antibodies in urine.
Tanaka A; Nalbandian G; Leung PS; Benson GD; Munoz S; Findor JA; Branch AD; Coppel RL; Ansari AA; Gershwin ME
Hepatology; 2000 Nov; 32(5):910-5. PubMed ID: 11050038
[TBL] [Abstract][Full Text] [Related]
10. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis.
Liu B; Shi XH; Zhang FC; Zhang W; Gao LX
Liver Int; 2008 Feb; 28(2):233-9. PubMed ID: 18251980
[TBL] [Abstract][Full Text] [Related]
11. Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis.
Dubel L; Tanaka A; Leung PS; Van de Water J; Coppel R; Roche T; Johanet C; Motokawa Y; Ansari A; Gershwin ME
Hepatology; 1999 Apr; 29(4):1013-8. PubMed ID: 10094940
[TBL] [Abstract][Full Text] [Related]
12. Molecular biology of the 2-oxo-acid dehydrogenase complexes and anti-mitochondrial antibodies.
Gershwin ME; Rowley M; Davis PA; Leung P; Coppel R; Mackay IR
Prog Liver Dis; 1992; 10():47-61. PubMed ID: 1296237
[TBL] [Abstract][Full Text] [Related]
13. Lipoteichoic acid may affect the pathogenesis of bile duct damage in primary biliary cirrhosis.
Haruta I; Hashimoto E; Kato Y; Kikuchi K; Kato H; Yagi J; Uchiyama T; Kobayash M; Shiratori K
Autoimmunity; 2006 Mar; 39(2):129-35. PubMed ID: 16698669
[TBL] [Abstract][Full Text] [Related]
14. Primary biliary cirrhosis. High proportions of B cells in blood and liver tissue produce anti-mitochondrial antibodies of several Ig classes.
Björkland A; Lööf L; Mendel-Hartvig I; Tötterman TH
J Immunol; 1994 Sep; 153(6):2750-7. PubMed ID: 8077679
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of serum antimitochondrial antibody-negative primary biliary cirrhosis.
Zhang FK; Jia JD; Wang BE
Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):288-91. PubMed ID: 15138128
[TBL] [Abstract][Full Text] [Related]
16. Detection of IgA, IgM, and IgG subclasses of anti-M2 antibody by immunoblotting in autoimmune cholangitis: is autoimmune cholangitis an early stage of primary biliary cirrhosis?
Nakajima M; Shimizu H; Miyazaki A; Watanabe S; Kitami N; Sato N
J Gastroenterol; 1999 Oct; 34(5):607-12. PubMed ID: 10535489
[TBL] [Abstract][Full Text] [Related]
17. Serum secretory IgA, IgA1 and IgA2 subclasses in inflammatory bowel and chronic liver diseases.
Soppi E; Granfors K; Leino R
J Clin Lab Immunol; 1987 May; 23(1):15-7. PubMed ID: 3612757
[TBL] [Abstract][Full Text] [Related]
18. No prognostic significance of antimitochondrial antibody profile testing in primary biliary cirrhosis.
Vleggaar FP; van Buuren HR
Hepatogastroenterology; 2004; 51(58):937-40. PubMed ID: 15239218
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic significance of antimitochondrial antibody profiles A-D in primary biliary cirrhosis].
Klein R; Berg PA
Dtsch Med Wochenschr; 1988 Oct; 113(40):1549-53. PubMed ID: 3168779
[TBL] [Abstract][Full Text] [Related]
20. Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic.
Bogdanos DP; Baum H; Okamoto M; Montalto P; Sharma UC; Rigopoulou EI; Vlachogiannakos J; Ma Y; Burroughs AK; Vergani D
Hepatology; 2005 Aug; 42(2):458-65. PubMed ID: 16025495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
